title: Intracardiac Thrombosis after Emergent Prothrombin Complex Concentrate Administration for Warfarin Reversal.
authors.affiliation: From the Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania (J.E.G.).
authors.forename: Jordan E
authors.initials: JE
authors.lastname: Goldhammer
authors.forename: Magdalena J
authors.initials: MJ
authors.lastname: Bakowitz
authors.forename: Bonnie L
authors.initials: BL
authors.lastname: Milas
authors.forename: Prakash A
authors.initials: PA
authors.lastname: Patel
mesh_terms: D000368:Aged; D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D006801:Humans; D019934:International Normalized Ratio; D013927:Thrombosis / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D014463:Ultrasonography; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates; D014859:Warfarin